By improving lipid metabolism (lowering cholesterol) and lowering blood pressure, GLP-1 agonists contribute to cardiovascular health maintenance and disease prevention ( Nature )
USA 84 , 64346437 (1987)
[DOI] [PMC free article] [PubMed] [Google Scholar] 138.Dhatariya K., Bain S.C., Buse J.B., Simpson R., Tarnow L., Kaltoft M.S., Stellfeld M., Torne K., Pratley R.E., LEADER Publication Committee on behalf of the LEADER Trial Investigators The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients with Type 2 Diabetes at High Risk for Cardiovascular Events: Results from the LEADER Trial
Each peptide vial is developed specifically for controlled laboratory environments where advanced peptide-related scientific studies and professional laboratory operations are conducted
J Am Med Assoc (2007) 298(2):194206
In the surgical recovery trials, ipamorelin was described as well-tolerated